Portuguese scientist wins award for transforming tumours into their own vaccines
The approach, which originated in Portugal, reprograms tumour cells to trigger immunity against the tumour itself. Human clinical trials are scheduled for 2027.
Público

Latest news and stories about cancer therapy in Portugal for expats and residents.
This page has only 1 story and is not indexed by search engines.
The approach, which originated in Portugal, reprograms tumour cells to trigger immunity against the tumour itself. Human clinical trials are scheduled for 2027.
